Intranasal administration of medications is on the rise for both on and off label uses. Dr. Mark Donaldson, Associate Principal and Dr. Philippe Mentler Senior Consulting Director, both at Vizient join host Gretchen Brummel for two episodes, sharing details on these drugs, their actions and indications.
Guest speakers:Mark Donaldson, BSP, RPH, PHARMD, FASHP, FACHEAssociate PrincipalVizient
Philippe Mentler, PHARMD, BCPSSenior Consulting DirectorVizient
Moderator:Gretchen Brummel, PharmD, BCPS
Intranasal administration of medications is on the rise for both on and off label uses. Dr. Mark Donaldson, Associate Principal and Dr. Philippe Mentler Senior Consulting Director, both at Vizient join host Gretchen Brummel for two episodes, sharing details on these drugs, their actions and indications.
Guest speakers:
Mark Donaldson, BSP, RPH, PHARMD, FASHP, FACHE
Associate Principal
Vizient
Philippe Mentler, PHARMD, BCPS
Senior Consulting Director
Vizient
Moderator:
Gretchen Brummel, PharmD, BCPS
Pharmacy Executive Director
Vizient Center for Pharmacy Practice Excellence
Show Notes:
[00:33 - 02:50] Why you would choose intra-nasal administration of an agent over some of the other non-oral or non-IV routes
[02:51 - 6:05] Some practical considerations people should be aware of, particularly when not to use these agents
[6:06 - 7:12] Some of the implications for the pediatric population
[7:13 - 12:10] What we have to look forward to in the future in this space
[12:11 - 13:46] What our frontline pharmacy staff should know about these medications
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Android
RSS Feed
View more
